Medical Hyperspectral Imaging (MHSI) can also support surgeons by offering them information that’s invisible to the naked eye – in real time. That medical hyperspectral image can be displayed on a screen. Or the hyperspectral information can be added as an overlay to the surgeon’s perspective by means of augmented reality glasses. This help surgeon to identify which anatomical structures to preserve when removing sick tissues.
Highlights
The global Medical Hyperspectral Imaging market was valued at US$ 18 million in 2022 and is anticipated to reach US$ 22 million by 2029, witnessing a CAGR of 3.1% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Americas has the largest global export quantity and manufacturers in Medical Hyperspectral Imaging (MHSI) market with about 44% market share in 2019, while the APAC is the second sales volume market for about 35% of the market and the number is still increasing.
In the industry, Headwall Photonics profits most in 2019 and recent years, while Resonon and IMEC ranked 2 and 3. The market share of them is 24.38%, 17.44% and 10.82% in 2019.The gap of market share is keep on enlarged due to different strategy.
Nowadays, there are three mainly types of Medical Hyperspectral Imaging (MHSI), including Visible + Near Infrared Light, Short-Wavelength Infrared and Other. And Visible + Near Infrared Light is the main type for Medical Hyperspectral Imaging (MHSI), and the Visible + Near Infrared Light reached a sales value of approximately 66.14% of global sales value.
Hyperspectral Imaging has a wide range of applications, the major applications including Diagnostic Centres, Hospitals, Research & Academic Centres
and Pharmaceutical & Biotechnology Companies, Pharmaceutical & Biotechnology Companies is the most important part, as the market share is nearly 42%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Hyperspectral Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Hyperspectral Imaging.
The Medical Hyperspectral Imaging market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Hyperspectral Imaging market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Hyperspectral Imaging manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Headwall Photonics Inc.
Specim Spectral Imaging Ltd.
Imec
Norsk Elektro Optikk A/S
Surface Optics Corp.
Telops Inc
Segment by Type
Visible/Near-Infrared(VNIR)
Short-Wave Infrared (SWIR)
Mid-Wave Infrared (MWIR)
Long-Wave Infrared (LWIR)
Others (UV-Vis, FT-IR, Combined Technology, etc.)
Segment by Application
Medical Diagnostics
Image Guided Surgery
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Hyperspectral Imaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Hyperspectral Imaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Medical Hyperspectral Imaging Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope of Medical Hyperspectral Imaging
1.2 Medical Hyperspectral Imaging Segment by Type
1.2.1 Global Medical Hyperspectral Imaging Âé¶¹Ô´´ Value Comparison by Type (2023-2029)
1.2.2 Visible/Near-Infrared(VNIR)
1.2.3 Short-Wave Infrared (SWIR)
1.2.4 Mid-Wave Infrared (MWIR)
1.2.5 Long-Wave Infrared (LWIR)
1.2.6 Others (UV-Vis, FT-IR, Combined Technology, etc.)
1.3 Medical Hyperspectral Imaging Segment by Application
1.3.1 Global Medical Hyperspectral Imaging Âé¶¹Ô´´ Value by Application: (2023-2029)
1.3.2 Medical Diagnostics
1.3.3 Image Guided Surgery
1.3.4 Others
1.4 Global Medical Hyperspectral Imaging Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Medical Hyperspectral Imaging Revenue 2018-2029
1.4.2 Global Medical Hyperspectral Imaging Sales 2018-2029
1.4.3 Global Medical Hyperspectral Imaging Âé¶¹Ô´´ Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Hyperspectral Imaging Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Medical Hyperspectral Imaging Sales Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.2 Global Medical Hyperspectral Imaging Revenue Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.3 Global Medical Hyperspectral Imaging Average Price by Manufacturers (2018-2023)
2.4 Global Medical Hyperspectral Imaging Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Hyperspectral Imaging, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Hyperspectral Imaging, Product Type & Application
2.7 Medical Hyperspectral Imaging Âé¶¹Ô´´ Competitive Situation and Trends
2.7.1 Medical Hyperspectral Imaging Âé¶¹Ô´´ Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Hyperspectral Imaging Players Âé¶¹Ô´´ Share by Revenue
2.7.3 Global Medical Hyperspectral Imaging Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Hyperspectral Imaging Retrospective Âé¶¹Ô´´ Scenario by Region
3.1 Global Medical Hyperspectral Imaging Âé¶¹Ô´´ Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Hyperspectral Imaging Global Medical Hyperspectral Imaging Sales by Region: 2018-2029
3.2.1 Global Medical Hyperspectral Imaging Sales by Region: 2018-2023
3.2.2 Global Medical Hyperspectral Imaging Sales by Region: 2024-2029
3.3 Global Medical Hyperspectral Imaging Global Medical Hyperspectral Imaging Revenue by Region: 2018-2029
3.3.1 Global Medical Hyperspectral Imaging Revenue by Region: 2018-2023
3.3.2 Global Medical Hyperspectral Imaging Revenue by Region: 2024-2029
3.4 North America Medical Hyperspectral Imaging Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Medical Hyperspectral Imaging Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Hyperspectral Imaging Sales by Country (2018-2029)
3.4.3 North America Medical Hyperspectral Imaging Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medical Hyperspectral Imaging Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Medical Hyperspectral Imaging Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Hyperspectral Imaging Sales by Country (2018-2029)
3.5.3 Europe Medical Hyperspectral Imaging Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Hyperspectral Imaging Âé¶¹Ô´´ Facts & Figures by Country
3.6.1 Asia Pacific Medical Hyperspectral Imaging Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Hyperspectral Imaging Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Hyperspectral Imaging Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medical Hyperspectral Imaging Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Medical Hyperspectral Imaging Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Hyperspectral Imaging Sales by Country (2018-2029)
3.7.3 Latin America Medical Hyperspectral Imaging Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Hyperspectral Imaging Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Medical Hyperspectral Imaging Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Hyperspectral Imaging Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Hyperspectral Imaging Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Hyperspectral Imaging Sales by Type (2018-2029)
4.1.1 Global Medical Hyperspectral Imaging Sales by Type (2018-2023)
4.1.2 Global Medical Hyperspectral Imaging Sales by Type (2024-2029)
4.1.3 Global Medical Hyperspectral Imaging Sales Âé¶¹Ô´´ Share by Type (2018-2029)
4.2 Global Medical Hyperspectral Imaging Revenue by Type (2018-2029)
4.2.1 Global Medical Hyperspectral Imaging Revenue by Type (2018-2023)
4.2.2 Global Medical Hyperspectral Imaging Revenue by Type (2024-2029)
4.2.3 Global Medical Hyperspectral Imaging Revenue Âé¶¹Ô´´ Share by Type (2018-2029)
4.3 Global Medical Hyperspectral Imaging Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Hyperspectral Imaging Sales by Application (2018-2029)
5.1.1 Global Medical Hyperspectral Imaging Sales by Application (2018-2023)
5.1.2 Global Medical Hyperspectral Imaging Sales by Application (2024-2029)
5.1.3 Global Medical Hyperspectral Imaging Sales Âé¶¹Ô´´ Share by Application (2018-2029)
5.2 Global Medical Hyperspectral Imaging Revenue by Application (2018-2029)
5.2.1 Global Medical Hyperspectral Imaging Revenue by Application (2018-2023)
5.2.2 Global Medical Hyperspectral Imaging Revenue by Application (2024-2029)
5.2.3 Global Medical Hyperspectral Imaging Revenue Âé¶¹Ô´´ Share by Application (2018-2029)
5.3 Global Medical Hyperspectral Imaging Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Headwall Photonics Inc.
6.1.1 Headwall Photonics Inc. Corporation Information
6.1.2 Headwall Photonics Inc. Description and Business Overview
6.1.3 Headwall Photonics Inc. Medical Hyperspectral Imaging Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Headwall Photonics Inc. Medical Hyperspectral Imaging Product Portfolio
6.1.5 Headwall Photonics Inc. Recent Developments/Updates
6.2 Specim Spectral Imaging Ltd.
6.2.1 Specim Spectral Imaging Ltd. Corporation Information
6.2.2 Specim Spectral Imaging Ltd. Description and Business Overview
6.2.3 Specim Spectral Imaging Ltd. Medical Hyperspectral Imaging Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Specim Spectral Imaging Ltd. Medical Hyperspectral Imaging Product Portfolio
6.2.5 Specim Spectral Imaging Ltd. Recent Developments/Updates
6.3 Imec
6.3.1 Imec Corporation Information
6.3.2 Imec Description and Business Overview
6.3.3 Imec Medical Hyperspectral Imaging Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Imec Medical Hyperspectral Imaging Product Portfolio
6.3.5 Imec Recent Developments/Updates
6.4 Norsk Elektro Optikk A/S
6.4.1 Norsk Elektro Optikk A/S Corporation Information
6.4.2 Norsk Elektro Optikk A/S Description and Business Overview
6.4.3 Norsk Elektro Optikk A/S Medical Hyperspectral Imaging Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Norsk Elektro Optikk A/S Medical Hyperspectral Imaging Product Portfolio
6.4.5 Norsk Elektro Optikk A/S Recent Developments/Updates
6.5 Surface Optics Corp.
6.5.1 Surface Optics Corp. Corporation Information
6.5.2 Surface Optics Corp. Description and Business Overview
6.5.3 Surface Optics Corp. Medical Hyperspectral Imaging Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Surface Optics Corp. Medical Hyperspectral Imaging Product Portfolio
6.5.5 Surface Optics Corp. Recent Developments/Updates
6.6 Telops Inc
6.6.1 Telops Inc Corporation Information
6.6.2 Telops Inc Description and Business Overview
6.6.3 Telops Inc Medical Hyperspectral Imaging Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Telops Inc Medical Hyperspectral Imaging Product Portfolio
6.6.5 Telops Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Hyperspectral Imaging Industry Chain Analysis
7.2 Medical Hyperspectral Imaging Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Hyperspectral Imaging Production Mode & Process
7.4 Medical Hyperspectral Imaging Sales and Âé¶¹Ô´´ing
7.4.1 Medical Hyperspectral Imaging Sales Channels
7.4.2 Medical Hyperspectral Imaging Distributors
7.5 Medical Hyperspectral Imaging Customers
8 Medical Hyperspectral Imaging Âé¶¹Ô´´ Dynamics
8.1 Medical Hyperspectral Imaging Industry Trends
8.2 Medical Hyperspectral Imaging Âé¶¹Ô´´ Drivers
8.3 Medical Hyperspectral Imaging Âé¶¹Ô´´ Challenges
8.4 Medical Hyperspectral Imaging Âé¶¹Ô´´ Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Headwall Photonics Inc.
Specim Spectral Imaging Ltd.
Imec
Norsk Elektro Optikk A/S
Surface Optics Corp.
Telops Inc
Ìý
Ìý
*If Applicable.